# Pliant Therapeutics, Inc.: Form 8-K, filed May 1, 2023

- Company: [Pliant Therapeutics, Inc.](/companies/plrx.md) (CIK 1746473)
- Form: 8-K
- Filed: 2023-05-01
- Accepted by EDGAR: May 1, 2023, 06:08 ET
- Period: 2023-04-30
- Accession: 0001193125-23-128616
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1746473/000119312523128616/d440511d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1746473/000119312523128616/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1746473/000119312523128616/d440511d8k.htm

Filed May 1, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-128616. Last ingested by Listed: Nov 13, 2026, 15:38 ET. No prices; not investment advice.
